Adherence to the new British Society for Rheumatology Psoriatic Arthritis guidelines for anti-tumour necrosis factor therapy

被引：0
|
作者：
Farquhar, K.
Reid, M.
Hanlon, S.
Perry, M. E.
机构：
[1] Royal Alexandra Hosp, Dept Rheumatol, Edmonton, AB, Canada
[2] Inverclyde Royal Hosp, Dept Rheumatol, Greenock, Scotland
来源：
SCOTTISH MEDICAL JOURNAL | 2015年 / 60卷 / 03期
关键词：
Psoriatic arthritis; biologic therapy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E14 / E15
页数：2
相关论文
共 50 条
  • [1] Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)
    Deighton, C. M.
    George, E.
    Kiely, P. D. W.
    Ledingham, J.
    Luqmani, R. A.
    Scott, D. G. I.
    RHEUMATOLOGY, 2006, 45 (06) : 649 - 652
  • [2] Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
    Amr A Saad
    Darren M Ashcroft
    Kath D Watson
    Kimme L Hyrich
    Peter R Noyce
    Deborah PM Symmons
    Arthritis Research & Therapy, 11
  • [3] Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
    Saad, Amr A.
    Ashcroft, Darren M.
    Watson, Kath D.
    Hyrich, Kimme L.
    Noyce, Peter R.
    Symmons, Deborah P. M.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (02)
  • [4] REVIEW OF PSORIATIC ARTHRITIS IN THE WEST MIDLANDS: ELIGIBILITY FOR ANTI-TUMOUR NECROSIS FACTOR THERAPY UNDER THE NICE GUIDELINES
    Bateman, James
    Cardy, Caroline M.
    Khan, Sophia Y.
    Menon, Ajit
    Obrenovic, Karen
    Rowe, Ian F.
    Erb, Nicola
    RHEUMATOLOGY, 2009, 48 : I57 - I58
  • [5] Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register
    Harrison, M. J.
    Dixon, W. G.
    Watson, K. D.
    King, Y.
    Groves, R.
    Hyrich, K. L.
    Symmons, D. P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) : 209 - 215
  • [6] Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Mercer, Louise K.
    Lunt, Mark
    Low, Audrey L. S.
    Dixon, William G.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1087 - 1093
  • [7] THE RISK OF SOLID CANCER IN PATIENTS RECEIVING ANTI-TUMOUR NECROSIS FACTOR THERAPY FOR RHEUMATOID ARTHRITIS: RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER
    Mercer, Louise
    Galloway, James
    Low, Audrey
    Watson, Kath
    Lunt, Mark
    Dixon, William
    Symmons, Deborah
    Hyrich, Kimme
    RHEUMATOLOGY, 2012, 51 : 40 - 40
  • [8] DOES DEPRESSION AFFECT RESPONSE TO ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS? RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER
    Davies, Rebecca
    Mercer, Louise
    Galloway, James
    Low, Audrey
    Watson, Kath
    Lunt, Mark
    Symmons, Deborah
    Hyrich, Kimme
    RHEUMATOLOGY, 2012, 51 : 161 - 162
  • [9] Opportunistic Infections in Patients Exposed to Anti-Tumour Necrosis Factor Therapy: Results From the British Society for Rheumatology Biologics Register
    Galloway, James B.
    Low, Audrey S. L.
    Mercer, Louise K.
    Dixon, William G.
    Ustianowski, Andrew
    Lunt, Mark
    Watson, Kath D.
    Hyrich, Kimme L.
    Symmons, Deborah P. M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S988 - S988
  • [10] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
12345